About Serigen
Serigen is a company based in Pune (India) founded in 2015 by Swati Shukla, Anuya Nisal, and Premnath Venugopalan.. Serigen has raised $2.33 million across 4 funding rounds from investors including BioAngels, Sparrow Technologies and Indian Angel Network. Serigen offers products and services including Serioss, Seriderm, and Serimat. Serigen operates in a competitive market with competitors including MiMedx Group, Ossio, Theradaptive, EpiBone and Biocomposites, among others.
- Headquarter Pune, India
- Founders Swati Shukla, Anuya Nisal, Premnath Venugopalan
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Serigen Mediproducts Private Limited
- Date of Incorporation 03 Feb, 2015
- Jurisdiction Pune City, Maharashtra, India
-
Annual Revenue
$15.89 K (USD)126.46as on Mar 31, 2022
-
Net Profit
$-131.46 K (USD)-7.08as on Mar 31, 2022
-
EBITDA
$-138.29 K (USD)-9.94as on Mar 31, 2022
-
Total Equity Funding
$2.33 M (USD)
in 4 rounds
-
Latest Funding Round
$1.19 M (USD), Seed
Aug 30, 2024
-
Investors
BioAngels
& 46 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Serigen
Serigen offers a comprehensive portfolio of products and services, including Serioss, Seriderm, and Serimat. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Osteoconductive filler for bone cavities caused by trauma or infection.
Absorbent dressing that accelerates healing of diabetic ulcers and burns.
Engineered matrix for promoting regeneration of soft tissues.
Funding Insights of Serigen
Serigen has successfully raised a total of $2.33M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $1.19 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Seed — $1.2M
-
First Round
First Round
(15 Jan 2020)
- Investors Count 47
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2024 | Amount | Seed - Serigen | Valuation | Indian Angel Network , Colossa Ventures |
|
| Mar, 2023 | Amount | Seed - Serigen | Valuation | BioAngels | |
| Jul, 2022 | Amount | Seed - Serigen | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Serigen
Serigen has secured backing from 47 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include BioAngels, Sparrow Technologies and Indian Angel Network. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Angel investor network investing in early-stage startups
|
Founded Year | Domain | Location | |
|
Investments are directed by Colossa Ventures toward diverse tech sectors.
|
Founded Year | Domain | Location | |
|
Investment and support platform for biotech and related startups in India.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Serigen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Serigen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Serigen Comparisons
Competitors of Serigen
Serigen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MiMedx Group, Ossio, Theradaptive, EpiBone and Biocomposites, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| domain | founded_year | HQ Location |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| domain | founded_year | HQ Location |
Therapeutic delivery platform is developed for orthopedic clinical indications.
|
|
| domain | founded_year | HQ Location |
Developer of stem cells to regrow damaged bones
|
|
| domain | founded_year | HQ Location |
Synthetic calcium composites are developed for bone repair and regeneration.
|
|
| domain | founded_year | HQ Location |
Implants for bone and cartilage regeneration are developed and provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Serigen
Frequently Asked Questions about Serigen
When was Serigen founded?
Serigen was founded in 2015 and raised its 1st funding round 5 years after it was founded.
Where is Serigen located?
Serigen is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Who is the current CEO of Serigen?
Anuya Nisal is the current CEO of Serigen. They have also founded this company.
Is Serigen a funded company?
Serigen is a funded company, having raised a total of $2.33M across 4 funding rounds to date. The company's 1st funding round was a Seed of $433.4K, raised on Jan 15, 2020.
What is the annual revenue of Serigen?
Annual revenue of Serigen is $15.89K as on Mar 31, 2022.
What does Serigen do?
Developer of protein-based tissue regeneration products for orthopedics. It uses natural silk proteins to develop tissue regeneration products such as Serioss for bone tissue repair, Serimat for soft tissue regeneration, and Seriderm for wound healing.
Who are the top competitors of Serigen?
Serigen's top competitors include EpiBone, Theradaptive and MiMedx Group.
What products or services does Serigen offer?
Serigen offers Serioss, Seriderm, and Serimat.
Who are Serigen's investors?
Serigen has 47 investors. Key investors include BioAngels, Sparrow Technologies, Indian Angel Network, Colossa Ventures, and Shantanu Deshpande.
What is Serigen's valuation?
The valuation of Serigen is $7.86M as of Mar 2023.